Purchases and Sales Made in Q1 2023 in Bright Minds Biosciences Inc. (DRUG)
This table provides information about the institutional ownership of Bright Minds Biosciences Inc. (DRUG) during Q1 2023. The information is specifically focused on institutions that hold shares of BRIGHT MINDS BIOSCIENCES INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 09, 2023
Q1 2023
|
Advisor Shares Investments LLC
Bethesda, MD |
BUY
|
- |
134K+ 42.65% |
$55.1K - $117K
|
449K
$17.7M
|
|
Apr 27, 2023
Q1 2023
|
Sawtooth Solutions, LLC
|
BUY
|
- |
46.2KNew |
$18.9K - $40.2K
|
46.2K
$1.82M
|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
27.7KNew |
$11.4K - $24.1K
|
27.7K
$1.09M
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
BUY
|
- |
5.69K+ 109.23% |
$2.33K - $4.95K
|
10.9K
$430K
|
|
May 15, 2023
Q1 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
218+ 11.7% |
$89.4 - $190
|
2.08K
$82.1K
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|